Core Dynamics Announces New Financing Allowing an Expansion Into Key Markets and New Product Development

ORANGEBURG, N.Y. , April 20, 2009 (GLOBE NEWSWIRE) -- Core Dynamics announced
today that it has recently closed on a new financing round of US$17.9 million.
The new financing came from institutional and private investors and will
provide the necessary capital to realize both its short and long term strategic
plans. 

"This new capital coupled with the recent development of a new process for
freeze drying human stem cells to be stored at room temperature will provide
the company with a significant platform for growth," stated Sachi Norman, CEO
of Core Dynamics. 

"Core Dynamics has primarily focused on only a small segment of the cell
therapy market with a very specific product. Having these funds will now allow
us to increase our sales footprint both in and outside the U.S. as well as
bring new products to market that will appeal to a broader range of customers,"
said Revital Rodovsky, CFO. 

For more information about MTG technology visit Core Dynamics at booth #3747 at
the BIO 2009 international meeting. 

About Core Dynamics

Core Dynamics, with offices in New York and research and development facilities
in Ness Ziona, Israel, is a pioneering biotechnology company focused on
advanced cell preservation technologies. Core Dynamics will revolutionize the
fields of cell therapy and transfusion medicine by dramatically enhancing
product stability and providing new clinical applications not possible with
conventional technology. Additional information can be found at
www.coredynamics.com. 

Forward-Looking Statements

This press release contains forward-looking statements about Core Dynamics,
including projections about its business and the cell therapy market. These
forward-looking statements are not guarantees of future performance and actual
results could differ. 

CONTACT: Core Dynamics
         Sachi Norman, CEO
         (301) 300-7412
         sachin@coredynamics.com